ICL Group Ltd

Ladies and gentlemen, thank you for standing by and welcome to the ICL Analyst Conference Call. Our presentation today will be followed by a question and answer session, at which time, if you wish to ask a question, you'll need to press star 1 on your telephone. I must advise you that this conference is being recorded today. If you experience any technical difficulties, please press star 0 on your telephone. I'd now like to hand the call over to the first speaker today, Peggy Riley-Sarp, Vice President of Global Investor Relations. Please go ahead, ma'am.

Thank you. Hello, everyone. I'm Peggy Riley-Tharp, Vice President of Global Investor Relations. I'd like to welcome you and thank you for joining us today for our first quarter 2021 conference call. This event is being livecast on our website at icl-group.com. Earlier today, we filed our reports with the securities authorities and the stock exchanges in the U.S. and in Israel. Those reports, as well as the press release, are available on our website. There will be a replay of the webcast available a few hours after the meeting, and a transcript will be available shortly thereafter. The presentation, which will be reviewed today, is also filed with the securities authorities and is available on our website. Please be sure to review the disclaimer on slide 2. Our comments today will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are not guarantees of future performance. The company undertakes no obligation to update any information discussed on this call at any time. We will begin with a presentation by our CEO, Mr. Raviv Zoller, followed by Mr. Colby Altman, our CFO. After the presentation, we will open the line for the Q&A session. Raviv, please.

Thank you, Peggy, and welcome, everyone. I'm pleased to report solid first quarter earnings, which were driven by record results across all our specialty businesses as we executed on our stated growth strategy. We continued to create strong cash generation and margin expansion, supported by improved market fundamentals, which began in the latter part of 2020, continued into the first quarter, and now the second quarter. Specifically on slide three, you can see some highlights from each division. Industrial products record quarter was driven by strong demand and high market prices and bolstered by long-term contracts. Our potash operations delivered another record for first quarter production at the Dead Sea, and our team in Spain completed the launch of the ramp connecting our Cabanases mine and Soria plant. Phosphate Solutions delivered record sales in EBITDA, including our YPH joint venture, driven by product innovation, cost efficiencies, and the continued shift to specialties. Innovative Ag Solutions also had a remarkable quarter, as results benefited from the unified sales and marketing organization, higher volume, and improved product mix. Each of these divisions is focused on one or more of our strategic target markets and slide four shows the progress we are making in these efforts as we work together to create impact for a sustainable future for our communities, our employees, and our investors. In our industrial end markets, our recent investments in capacity have enabled us to meet booming long-term demand for our specialty offerings. For our food focus, while a smaller part of our business today, our commitment should be apparent following the strategic additions we have made to our leadership team and our board of directors. I would like to welcome both Chris Millington to our executive team as our new head of food specialties and Gadi Lesson to our board of directors. Both of these individuals have significant food industry experience, spanning a wide array of segments and categories, and we're pleased to have them on our team. I would also like to welcome Elad Aronson to ICL, who joins us as President of Innovative Ag Solutions. Turning to our agriculture end market, our existing operations, when combined with our recent acquisition announcements, position ICL as the leading specialty plant nutrition company in Brazil, one of the world's fastest growing agriculture markets. Turning to slide five, you can see our progress over the past four quarters with sales of $1.5 billion in the first quarter, and this is the first time we've hit this milestone since 2014. EBITDA of $295 million was up nearly 20% over the prior year's first quarter, and we continue to report strong cash generation with operating cash flow of $206 million up $40 million year over year. Our complete first quarter results are on slide six, where you can see growth in every single financial metric. This success reflects the results of our strategic focus on key specialty end markets, where we are committed to growing as we move forward. Moving on to slide seven, let's begin our segment review with industrial product. where we had record sales of $398 million, up 9% versus the first quarter of 2020, and EBITDA of $122 million. This business continued to benefit from our strategic shift to long-term contracts as the end market for bromine and phosphorus-based flame retardants exhibited strong demand, including electronics, construction, and textiles, and with the automotive market beginning to pick up. While sales of clear brine fluids are lagging along with the recovery in oil and gas, we did have a record quarter in specialty minerals. This was driven by increased sales to the pharma and body care markets, as well as higher prices and sales of magnesium chloride due to more traditional winter weather in the United States. Elemental bromine prices have continued to increase since the end of 2020. However, We've also seen some increases in freight rates and raw material prices and experienced some raw material constraints. We're at full capacity at our new TBBA plant in Nile Trovov and are already considering expanding capacity for additional long-term agreements. As always, we remain focused on our value over volume in this specialty business. Turning now to slide eight and a review of Putash. where global grain demand supported higher putash prices, and we saw strong growth in sales in EBITDA, up 23% and 25% respectively. Our average realized price per ton of $257 in the quarter was up only 3% year over year, which indicates recent price increases will have a more significant impact in the second and third quarters. Just after the first quarter ended, we signed an agreement with IPL, India's largest importer of putash, for $280 per ton, $50 per ton higher than the previous contract. On the potash production side, we had a record first quarter, with the Dead Sea producing more than 1 million tons. In Spain, as I mentioned earlier, the ramp between the Cabanaces mine and Suria plant is now operational, following a three-week shutdown beginning in late March. This project is expected to increase capacity with the annual run rate anticipated to reach approximately 1 million tons by the end of 2021. At ICL Bowlby, polysulfate production was up 3% year over year, while sales volume increased significantly, up 38% versus the first quarter of 2020. Turning to slide nine and our phosphate solutions division, which reported record sales and EBITDA of $545 million and $94 million respectively. These achievements follow almost two years of steady growth driven by product innovation and cost efficiencies as business continues to shift from traditional phosphate to specialties. Our YPH joint venture had its best quarter ever with higher prices, increased volume, and improved mix, as well as procurement and production efficiencies. Overall commodity price improvement, which began in the second half of 2020, continued in the first quarter, along with increased prices for raw materials and higher freight rates. For specialties, we had strong results for phosphate food specialties with higher volumes, lower operating costs, and favorable exchange rates. Food demand remained stable, as it did through 2020, and we benefited from our strong global presence and the reputation our customers could rely on, combined with our regional production network. For our industrial solutions, we began to see end-market demand return, while phosphate fertilizers saw continued significant recovery across all geographies. Finally, turning to slide 10 in our innovative ag solutions, a business which had a remarkable quarter, with sales of $241 million, up more than 20%, while EBITDA of nearly $30 million was up more than 50%. We saw strong demand in most of our target markets with higher volumes and improved product mix. We also maximized lower price raw materials and stock, but we expect these cost inputs to increase in the second quarter. Most importantly, Innovative Ag Solutions benefited from the unified sales and marketing organization that we put in place last year and from geographical expansion and new product launches. The division also had record turf and ornamental sales, up more than 25%, with higher volume following a rather soft first quarter of last year. Specialty agriculture also had a good quarter, with sales up double digits. Overall, Innovative Ag Solutions benefited from leading market share and sales of higher margin products, and we expect greater contribution from this business following our recent acquisition announcements in Brazil. And there are more details on slide 11. In mid-March, we announced the acquisition of South American plant nutrition business of Compass Minerals for approximately $400 million. When combined with our existing operations in Brazil and our recent FertilAqua acquisition, ICO will become Brazil's leading specialty plant nutrition company, and this will allow us to deliver the critical mass we have been seeking in Brazil. The Compass operations cover a broad range of solutions, and include all key crops in Brazil with a presence in 25 out of 26 Brazilian states. Importantly, this business serves more than 32,000 farms, both directly and indirectly, but notably derives approximately 50% of total sales from its direct-to-farm business. Our acquisitions in Brazil expand both our product portfolio and our profitability while providing a seasonal balance of business between the northern and southern hemispheres. In addition, we expect to realize significant commercial and operational benefits. Importantly, both FertilAqua and Compass bring a wealth of experience to ICL, and we want to welcome them as they join our extended team in Brazil. Before I turn the call over to Kobi for a review of the financials, I want to highlight our key takeaways on slide 12. In the first quarter, sales crossed $1.5 billion for the first time since 2014 as each business segment is driving toward its strategic targets. For industrial products, we've expanded bromine compound capacity to meet demand as we shift to more profitable long-term contracts and we are looking at additional investments and innovation opportunities. As I mentioned earlier, Phosphate Specialties is delivering consistent growth as the business shifts from traditional phosphates to specialties. This includes alternative proteins and our new plant in St. Louis is expected to be operational in the third quarter. We hope to be able to welcome many of you to visit in the near future. Our Innovative Ag Solutions division delivered first quarter profitability in excess of our total profits for 2019. This business is poised to accelerate growth even further by leveraging our acquisitions in Brazil. And finally, our potash business remains on track and continues to maximize capacity and delivered yet another production record in the first quarter of 2021. With the ramp project complete in Spain, we will begin seeing additional capacity coming online for this division. This has been a fantastic quarter for ICL. And it would not have been possible without the truly talented team we have spread out across the globe. I would like to thank each and every one of them for their hard work and dedication this quarter and every day. With that, I'll turn the call over to Clubby.

Thank you, Raviv, and to all of you for joining us today as we report significant improvement in year-over-year results, which Raviv just reviewed. On slide 14, you can see that in addition to this performance, we also maintain our financial strength with liquidity of more than $1.1 billion. We maintain a high level of liquidity even after the funding of the fertile aqua acquisition early in January of this year, and more than $200 million of principal debt repayments during the quarter. In the first quarter, we delivered improvements in both operating cash flow and free cash flow, supported by strong execution and market fundamentals. Our 2.4 net debt to EBITDA ratio was down slightly from the fourth quarter of last year, and we have no major short or mid-term principal debt repayments on the horizon. On slide 15, you can see some of the commodity price improvement Aviv referenced. Recovery that began in the fourth quarter has continued into the first quarter, and we believe additional upside may be ahead. For the first quarter, our average potash realized price per ton of $257 was only 3% higher year over year, indicating recent price increases will be more evident in the second quarter and even more so in the third quarter. Phosphorus prices are also participating in the commodity price upcycle, and elemental bromine prices in China recently reached another record high, mainly due to strong demand and continued government regulatory restrictions. But if you turn to slide 16, you can also see the increases we are facing on the cost side. For example, the recovery trend in the phosphate market was followed by major raw material price increases, including sulfur. While this clearly affected phosphate commodities, higher freight rates impacted all of our divisions. With the entire marketplace feeling the impact of higher freight, It's an opportune time to remind you of our logistical advantage due to our proximity to key shipping routes. As in the past, we return our ability to get to market faster and at a lower cost. On slide 17, we have broken out our sales and profit to give you a better idea of where and how we benefited in the first quarter. This will also help you for your sum of the parts valuation models. Price and volumes both had a positive effect on our sales and EBITDA. However, as I just discussed, raw materials and transportation had a combined negative impact of nearly 30 million dollars. For this slide, I would also like to call out the continued shift of phosphate solutions to more specialty products, which now make up 54% of total sales and 51% of EBITDA. Turning to slide 18, you can see the contribution to sales and EBITDA by business. No matter how you look at it, the first quarter was an exceptional one for ICL with all the vision driving improvement. As a result, we are raising our guidance expectations and you can find the details on slide 19. For the full year, we now expect an adjusted EBITDA range of between $1,090,000,000 and $1,175,000,000. Clearly, the improved market conditions we saw in the first quarter, combined with prompt execution by our teams, made the high end of our previous guidance very achievable and this is reflected in our new range. And with that, I would like to thank you for joining and turn the call over to the operator for the Q&A.

Thank you. Ladies and gentlemen, if you wish to ask a question, please press star 1 on your telephone keypad and wait for your name to be announced by the operator. If you wish to cancel your request, please press the hash key. Once again, that's star 1 if you wish to ask a question. Please stand by while we compile the names. This will take a few moments. Your first question comes from the line of Alexander Jones of Bank of America. Please ask your question.

Great, thanks. Good afternoon, Raviv and Kobi. First question, if I may, on the guidance. Obviously, you did nearly $300 million of EBITDA this quarter, and you've highlighted that potash and phosphate prices continue to increase. Is there any reason why we shouldn't annualize this quarter, perhaps with a bit of an increase, and get to number above your guidance range? Or in other words, are you being more cautious because of any particular factors or just waiting to see how things play out?

Thanks for the question. As you recall, we're giving guidance for the first year in the history of the company. And we want to be very cautious about how we deliver guidance. And it's built bottom-up. We had no intention of changing guidance before mid-year. Not unfortunately, but when we gave guidance originally, we mentioned that we were basing it on existing prices, and prices have moved considerably. The recent April signing of the contract in India showed implies that for the rest of the year we have an upside of about $80 million, not taking into account some of the price moves in recent days. And we factored in about additional $30 million of logistic costs, so roughly about $50 million. And then we exceeded our plans for Q1 by about $20 million, so Those two factors, the net upside in put-ash prices and the overachievement in Q1, brought us to this update. Another thing that I want to clarify is that we're talking about a guidance that is basically 3.85 times EBITDA of the first quarter, which is roughly a linear extrapolation, whereas the fourth quarter is usually weaker for seasonal and other reasons. So that's pretty much how we got to the updated guidance bottom-up. I also want to clarify that this doesn't include any upside from the Brazilian acquisition, given that we don't have any final clarity on when the closing will happen. Right now, we're pretty optimistic that the results of Brazilian acquisition will be consolidated for most of the second half of the year. If that happens, then there'll be room for additional update of guidance as well. So again, it's bottom-up based on linear extrapolation and taking into account some update of pricing of potash, net of additional transportation logistic costs, and not taking into account the possible effect of the consolidation of recent Brazilian acquisition. I hope that clarifies. And again, keep in mind, yes, maybe we're a little conservative. It's the first year. We feel that we must be very, very responsible towards our shareholders, and we don't want to overpromise. We want to manage this carefully. We appreciate your patience.

Thanks, Ravi. That's very clear. Maybe one more question, if I may, specifically on industrial products. By my calculation, your volumes are up about 10% versus 2019 in this quarter. How would you expect that to evolve going forward into the next couple of quarters? Do you think there's any unsustainable element there where customers are restocking? Or on the opposite side, a couple of your competitors, one of them has been talking about issues related to flooding. their plant in the first quarter impacting volumes in the second and third. So is there any potential for market share gains? Thanks.

Okay. So fundamentally, we've gained market share and will continue to gain market share, but actually not from our competitors. But based on the strategic shift we made to long-term contracts, basically some of our customers that used to produce their own compounds have transferred production over to us. on a long-term basis. And this means that our market effectively grew and we grew market share, but not so much on the account of our competitors. Now, due to post-corona rebound, we, first of all, were sold out at least until the end of the third quarter. All of our capacity that we thought would take between one to two years to fill, all our capacity has been filled out, and we actually cannot accept additional orders. The unfortunate weather issue that affects our competitors... Unfortunately, we're not going to be able to benefit from that too much because we don't have the additional capacity that is necessary. Our additional capacity has been booked up. Some effect of that may be some additional acceleration in prices. We see broming prices at record highs at this point. So until there's... We are reaching out for some additional capacity, but in the short term, there's under-supply or over-demand in the market. And so... The short answer to your question is we're not going to be increasing market share additionally to what we already did in the next couple of quarters because we don't have enough capacity to do so.

Excellent. Thank you very much.

Thank you. The next question comes from the line of Tom . Please ask your question.

Thanks very much for the presentation. So just thinking a little bit about your position in Brazil, you talked about critical mass. Does that mean the dial is shifting now away from inorganic growth towards organic growth? Can you elaborate a little bit more on where you see this business going over the medium term and really what the Compass Minerals acquisition means crystallizes for ICL going forwards. That would be helpful. A second question is, you quoted raw material pressure in industrial products. Is that the code products that you're using for the polymers that you're citing now? I wasn't expecting to hear that terminology in industrial products, given your integration into the building, into the elemental forms. Those are my two questions.

Thank you. There's some raw materials that are critical for some of the flame retardants that we're producing that we saw some shortage in and as a result prices have gone up. We see that more of a logistical issue for production and now it seems like it's leveling out. We don't really see the pricing issue there because basically any significant price pressure from that side is pretty much rolled over to the ultimate customers. So that's the dynamic there. But can you remind me what your first question was? It's a great question and I was so excited about answering it, I lost it. So anyway, the way to look at it is that Brazil is the number one market in the world actually for specialty fertilizers. Brazil and China account for 70% of growth of global markets. As our strategy is to become leaders in this market, we're very significant in Europe and some other regions. A big component of our strategy is becoming significant in China and Brazil. In China, our strategy is based more on organic growth and leveraging some of the capabilities of our joint venture there. In Brazil, in order to reach a critical mass of production distribution, and it's not very effective to compete from outside going into a market that has a volatility in exchange rate and local inflation, so it was clear that we need significant production and distribution in Brazil. And we targeted a few companies, and fortunately for us, Because all the stars came into place, we are acquiring the leading player in Brazil. And pretty much that makes our dream come true. And this M&A is the basis for... for all of our business in Brazil. So some of our traditional business in Brazil will be consolidated into this new acquisition. And we have FertilAqua that's playing in the biostimulants niche of the market. And on that foundation, we intend to focus on organic growth in Brazil because both of these businesses are growing at double-digit rates. They have great distribution, great products. We're going to add to that additional capabilities that we bring from ICL, and that can enhance the organic growth. And although there is some non-Brazilian sales, very, very little, and there's potential based on the existing products to grow that. We're first and foremost going to focus on growing the business in Brazil. I guess the way to look at it is, The market we're targeting, the global market, is a $14 billion market. Growth is in China and Brazil. China, we're executing successfully organic growth. Brazil, the only way to do it, given currency, inflation, et cetera, is to get critical mass through M&A. And we're lucky enough to acquire the best company out there, leader in the market. And so we that currently have about 6% of global market are going to get to 9% and close to 10% through this new acquisition, actually two acquisitions, but mainly the recent acquisition in Brazil. Our leadership strategy has to do with becoming leaders in Brazil. This acquisition will make us leaders in Brazil, and from this point forward, the growth in Brazil will be first and foremost based on organic growth. Remember also that we have a strong commodity business in Brazil. We sell between half a billion to a billion dollars of potash and phosphates per year in Brazil as well. I hope that answers.

Thank you very much. Just to follow up on that, obviously you've got expertise in phosphates, expertise in potash. As you think about the building blocks of this business, do you think the need to secure nitrogen supply is critical given that NPKs play a strong role into the cash crops in Brazil?

I don't think that we're lacking in distribution capabilities for potash and phosphate. And I don't think that the main synergy or the main... or any main part of our execution strategy in Brazil has to do with complementing our ability to bring in phosphate or put ash or any other commodity into the Brazilian market. Compass Minerals, soon to be called ICL South America, is a very competent company, and we want to focus on specialty offerings and unique product offerings, and even more so on the direct relationships that exist with farmers. The great thing about Compass is that over 50% of the sales are direct to farmer, And that's very unique in the world of specialty fertilizer. We intend to capitalize on that.

Great. Thank you very much. Thanks for the very good talk.

Thank you.

Your next question comes from the line of Joel Jackson of BMO Capital Markets. Please ask your question.

Hi, this is Brie Murphy. I'm for Joel. Thanks for taking my question. Is ICL looking at minimizing potash tons to China and diverting them to higher priced markets instead? Or Is there not much flexibility there?

First of all, yes. In current market conditions, it makes more sense for us to sell elsewhere. We expect, though, that the conditions in China will improve because there's a significant disparity between the formal import price and the local price. I think there's a spread of over $100. So we think that there will be rationalization there probably before the year is over. So we expect new contract negotiations toward the end of this year. And in the meantime, to make sure that you get your answer, yes, we'll divert some of our China product elsewhere.

Okay, thank you. And then just on polysulfate, obviously sales volumes continue to ramp there. Is the business profitable yet? And if not, what needs to happen to get to profitability? Okay.

The business is not profitable yet. We still were producing at a rate a little lower than a million tons and we need to get to over a million tons. We feel that that will happen this year. The other side of it is that we need to demand a higher premium on the selling price than currently is happening. We expect that this will evolve over some more time as a premium is deserved for organic fertilizer, and we see we're getting those premiums in Europe, not so much in other territories. We're still challenged to demand the kind of premium that we need in order to turn the business to profitability. But we are making advances, and we feel that we're going in the right direction.

Thank you.

Thank you.

Thank you. The next question comes from Lawrence Alexander of Jefferies. Please ask your question.

Hi, everyone. This is Maria Melina on for Lawrence. Thanks for taking my question. Could you please comment or elaborate a bit more on the impact of the rising shipping cost? Is it a net benefit because it's keeping the cost curve or how do you see it shaping up this year?

Well, as I think Kobe mentioned and presented, in the long run it's to our advantage relative to competition because we're well positioned from a logistics perspective. In the short run, there's been a spike in transportation costs. So if on Indian contract the price increase is $50, $20 is additional freight costs. So we're netting an additional $30 out of $50. And, of course, one of the reasons that the negotiation ended up where it did is because the customers are starting to understand. And, of course, this will be the case elsewhere. We're selling in Brazil now at $3.65. Europe prices are going up. U.S. prices are going up in recent days. So the world is adjusting to the new freight and transportation costs.

Thank you. And just a short follow-up question. You mentioned a few markets that are still slower in recovery, such as automotive or oil and gas. Do you see any positive movement there? And how do you see it changing in 2021 and the rest of the year?

Yeah. Automotive is actually back now towards the back end of the first quarter. And in April, we saw one of our new facilities, one of the capacity upgrades was for an automotive flame retardant. And we thought that it would probably not fill up until the end of the year. And it's filled up over the past month and a half or so. And we see that automotive has actually come back since November, December. But given high level of inventories in automotive, it's taken some time to get down the supply chain. So we've only felt it recently. And most of the first quarter was soft. But from this point forward for the rest of the year, we see automotive fully recovered. Oil and gas, we think it's not going to completely recover until the end of the year. We have a very profitable line of clear-bind fluids. And to give you a sense of what has changed, it's gone down from over $50 million last year to a little over $30 million this year in the first quarter, which means that we've had a drop of $21 million in sales, which accounts for about 40% of total sales. It's actually much better than a quarter or two ago. I think we had a quarter, I don't remember if it was the second or the third quarter, but total sales were like $3 or $4 million. So it has come up, and in some regions of the world completely, but we expect that the recovery will take until the end of the year. I do admit that we didn't expect oil prices to rebound so quickly.

Thanks for providing the call-in.

Thank you.

Thank you. Once again, if you wish to ask a question, please press star 1 on your telephone and wait for your name to be announced. If you wish to cancel your request, please press the hash key. Your next question comes from the line of Mark Connolly of Stevens Inc. Please ask your question.

Hi, this is John Ryder on for Mark. So you've talked about how the automotive business has recovered nicely, but producers are continuing to talk about chip shortages. Do you have any view of whether the issues automakers are facing will impact your own demand maybe later on this year?

It's difficult to say because, as I mentioned, there's a lag of two or three quarters between whatever happens in the ed market of automotive until we feel it. But I think part of what we're feeling is also a certain shift to EV. Electric vehicles demand more electronic components that need flame retardants. So I think it's also... Not just the issue of total size, but also the mix of the new demand for product. It's a partial answer, but it's really all I have.

Right. That's helpful. And then can you just give us a little more color on the soft state specialties growth and where you think the growth will come over the next year, both in product and geography? Okay.

Sure. You know, we've said many times before that our strategy was to get from about 45% to about 70% specialties in the mix. And this quarter, we plan to be over 60%. But because of a good thing, because of the rise in commodity prices, we ended up at 54%, I believe. So We're growing steadily. The specialty business is driven mainly by growth in our food-related innovation, which is actually not just phosphate. Some of it is phosphate and some of it is alternative protein. And that business is growing at a rate of about 10% right now. And the EBITDA of the specialty business is currently about 13%. So it's a healthy business despite the relatively large investment and innovation, which we hope will bring good results for the future. Despite that investment, it's still a 13% EBITDA business, growing on the strength of food innovation, partly phosphate and partly alternative protein. The industrial specialty products have shown slower growth, almost no growth this quarter, but technical grade white phosphoric acid was up nicely. Okay.

Thank you very much.

Thank you.

Next question comes from the line of Anne de Plasse of Burgundy. Please ask your question.

Good morning, Radiv and Kobe. Congratulations on a really strong quarter. I wanted to ask you about potash. Could you talk a little bit about the strength of the upcycle that you're seeing? Maybe talk about what you expect for demand for the full year and kind of how you see the supply dynamics changing going forward the next year or two if you can. Thank you.

Sure. First of all, I'd like to use your question to call out that I guess in the past, the company's growth or performance was completely dependent on put-ash prices. And I sort of want to call out that if you look at the results of this quarter, then put-ash prices Prices went up by 3%. But if you look at the four divisions, Porash came in number three. And in fact, we happened to be a little late by about two weeks on the start of the connection of the ramp in Spain. And so our production halt started late. So we had better than expected results in Q1. By the way, we'll have a little less than we wanted in Q2 because of that. If that hadn't happened, PUDASH would have been fourth, fourth out of four divisions. Now, that's the good news for ICO because our strategy focusing on specialties is really coming through and we've created a growth that we can live with for the years that we planned until 2025 when we Intent to reach sustainable double-digit growth. So bromine based on long-term contracts and new developments. In agriculture, additional capacity M&A and product innovation. Food, I already talked about. Phosphate and food I already talked about. There are two things that we're doing. One, as you know, we increased capacity in the Dead Sea. We finalized in April the connection of the ramp in Spain, so we're poised to get to a million tons this year, and then we'll go to 1.3 million of capacity within the next two years. And luckily, in terms of timing, everything is coming together and potash prices are showing strength, resilience, I would say. We were selling in Brazil just a little over a year ago at $200 a ton and now $365. And I think prices in Brazil have gone up by almost $100 just in the last three or four months. So the dynamics of the pricing of potash look to be going up. As you know, we are a price taker in this market, so we can say that the demand is expected to be around 68 million tons. We read from the same sources as you do, and we think that that number seems reasonable. On the supply side, it's really a matter of discipline of Canadians, Russians. As I said, we're a price taker. And it seems that, as I mentioned, Brazil and the U.S., of course, and India now with a new contract. and hopefully we'll have a better China settlement by the end of the year. It looks that potash prices and fertilizer prices in general have to follow grain prices, and average grain prices have gone up by 100% over the past year. It doesn't look like they're slowing down. Some countries are increasing reserves, So all of those factors allow us to be optimistic and believe that pricing for the next year or two looks to be in the right direction. I hope that answers.

Thank you, Adi. Very helpful. And again, congratulations on the quarter and a lot of work for Turnaround in the last few years.

Thank you very much.

We have no further questions at this time. Please continue.

We'd like to thank you all for joining us on our first quarter call. We look forward to talking to you again after we report second quarter earnings. Good day.

That concludes the conference for today. Thank you for participating. You may all disconnect. Speakers, please stand by.